"Public reporting of patient outcomes is a key tool to drive improvements in health care delivery. Over the past 20 years, three states—New York (1991), Pennsylvania (2001), and Massachusetts (2005)—have instituted mandatory public reporting of outcomes for PCI. The idea behind public reporting is simple: collecting and publicly reporting performance will enable patients to choose high-quality hospitals and motivate clinicians to improve performance. However, critics worry that public reporting may create disincentives for physicians and hospitals to care for the sickest patients, potentially leading clinicians to avoid offering lifesaving procedures to these patients," according to background information in the article.
Karen E. Joynt, M.D., M.P.H., of the Harvard School of Public Health, Boston, and colleagues conducted a study to determine whether public reporting for PCI is associated with lower rates of PCI for patients with acute myocardial infarction (MI; heart attack) or with higher mortality rates in this population. The study was conducted using data from fee-for-service Medicare patients (49,660 from reporting states and 48,142 from nonreporting states) admitted with acute MI to U.S. acute care hospitals between 2002 and 2010. Analysis compared PCI and mortality rates between reporting states (New York, Massachusetts, and Pennsylvania) and regional non-reporting states (Maine, Vermont, New Hampshire, Connecticut, Rhode Island, Maryland, and Delaware). Changes in PCI rates over time in Massachusetts also were compared with rates in nonreporting states.
The researchers found that among patients admitted for an acute MI in 2010, those in public reporting states were significantly less likely to receive a PCI compared with the regional control group of patients in nonreporting states (unadjusted rates, 37.7 percent vs. 42.7 percent). "This was most pronounced in the ST-segment elevation myocardial infarction [STEMI; a certain pattern on an electrocardiogram following a heart attack] and the cardiogenic shock or cardiac arrest groups. The odds of receiving a PCI for patients in the non-ST-segment elevation myocardial infarction [NSTEMI; a type of heart attack with certain findings on an electrocardiogram] group in public reporting states vs. nonreporting states were similar (30.3 percent vs. 33.7 percent), whereas for the STEMI group (61.8 percent vs. 68.0 percent) and the cardiogenic shock or cardiac arrest group (41.5 percent vs. 46.7 percent), the odds were significantly lower. These differences were similar in the older (75 years or older) age group."
The authors also examined changes in PCI rates in Massachusetts, a state that initiated public reporting for PCI in the recent era. "In the pre-reporting period, patients in Massachusetts were similarly likely to undergo PCI when compared with patients in non-reporting states (unadjusted rates, 40.6 percent vs. 41.8 percent). However, by the postreporting period, the odds of receiving PCI had decreased in Massachusetts relative to nonreporting states (41.1 percent vs. 45.6 percent)." Differences were most pronounced for the 6,081 patients with cardiogenic shock or cardiac arrest (pre-reporting: 44.2 percent vs. 36.6 percent; postreporting: 43.9 percent vs. 44.8 percent).
The researchers also found no overall difference in 30-day mortality among patients with acute MI in public reporting vs. nonreporting states (unadjusted rates, 12.8 percent vs. 12.1 percent). Mortality was higher in the STEMI subgroup (13.5 percent vs. 11.0 percent).
The authors write that there are at least 2 possible explanations for why public reporting was associated with lower rates of PCI for patients admitted for an acute MI. "It is possible that many of the foregone procedures were futile or unnecessary, and public reporting focused clinicians on ensuring that only the most appropriate procedures were performed. Alternatively, public reporting may have led clinicians to avoid PCI in eligible patients because of concern over the risk of poor outcomes. Although policy makers have made efforts to ensure that risk adjustment models account for patient complexity, prior qualitative work suggests that clinicians remain concerned about receiving adequate 'credit' for the comorbid conditions of their own patient population. Our data cannot definitively differentiate between these 2 potential mechanisms."
"Strategies to help clinicians differentiate between patients likely to benefit from PCI and those for whom it would be futile are critically important. Promising work in this area is already underway. Providing real-time models of both risk and benefit may help physicians, patients, and families make more informed decisions about when to pursue PCI. Similarly, strategies to provide adequate credit for taking care of the sickest patients would also be useful."
(JAMA. 2012;308[14]:1460-1468. Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Funding for this study was provided by a grant from the National Heart, Lung, and Blood Institute. All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
Please Note: For this study, there will be multimedia content available, including the JAMA Report video, embedded and downloadable video, audio files, text, documents, and related links. This content will be available at 3 p.m. CT Tuesday, October 9 at this link.
Editorial: Public Reporting of PCI Outcomes and Quality of Care - One Step Forward and New Questions Raised
Maura Moscucci, M.D., M.B.A., of the University of Miami Miller School of Medicine, comments on the findings of this study in an accompanying editorial.
"Patients are often treated regardless of the perceived futility of the planned intervention. The study by Joynt et al confirms the possible unintended consequences of public reporting, while highlighting its association with (or lack of association with) clinical outcomes. In addition, these findings may help spearhead a new focus on procedures that, while perceived appropriate based on current use criteria, might not result in added benefit in selected patients."
(JAMA. 2012;308[14]:1478-1479. Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
###
To contact Karen E. Joynt, M.D., M.P.H., call Todd Datz at 617-432-8413 or email tdatz@hsph.harvard.edu. To contact editorial author Maura Moscucci, M.D., M.B.A., call Lisa Worley at 305-243-5184 or email lworley2@med.miami.edu.
END
